Melrose, MA, United States of America

Fan Yang

This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Fan Yang

Introduction

Fan Yang is an accomplished inventor based in Melrose, MA (US). He has made significant contributions to the field of chemiluminescent probes, which are essential for various applications in biomedical research. His work focuses on developing compounds that can aid in the identification and monitoring of proteins associated with diseases.

Latest Patents

Fan Yang holds a patent for chemiluminescent probes, specifically a compound of Formula (I): A-L-B (I), or a pharmaceutically acceptable salt thereof. This patent outlines compositions that include the compounds of Formula (I) and methods for using them to identify misfolding-prone or aggregating-prone proteins in samples. The applications of his invention extend to determining protein concentrations, imaging tissues, and diagnosing diseases related to protein misfolding.

Career Highlights

Fan Yang is currently associated with The General Hospital Corporation, where he continues to innovate and contribute to the field of biomedical research. His work has the potential to impact the diagnosis and treatment of various conditions linked to protein aggregation.

Collaborations

Fan Yang collaborates with notable colleagues, including Wei Yin and Jing Yang, who share his commitment to advancing research in this critical area.

Conclusion

Fan Yang's contributions to the field of chemiluminescent probes exemplify the importance of innovation in biomedical research. His work not only enhances our understanding of protein-related diseases but also paves the way for improved diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…